These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

991 related articles for article (PubMed ID: 20376313)

  • 1. Inhibition of mTOR by rapamycin abolishes cognitive deficits and reduces amyloid-beta levels in a mouse model of Alzheimer's disease.
    Spilman P; Podlutskaya N; Hart MJ; Debnath J; Gorostiza O; Bredesen D; Richardson A; Strong R; Galvan V
    PLoS One; 2010 Apr; 5(4):e9979. PubMed ID: 20376313
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Over-expression of heat shock factor 1 phenocopies the effect of chronic inhibition of TOR by rapamycin and is sufficient to ameliorate Alzheimer's-like deficits in mice modeling the disease.
    Pierce A; Podlutskaya N; Halloran JJ; Hussong SA; Lin PY; Burbank R; Hart MJ; Galvan V
    J Neurochem; 2013 Mar; 124(6):880-93. PubMed ID: 23121022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of moxibustion on autophagy in mice with Alzheimer's disease based on mTOR/p70S6K signaling pathway].
    Wu YY; Song XG; Zhu CF; Cai SC; Ge X; Wang L; Jia YM
    Zhongguo Zhen Jiu; 2022 Sep; 42(9):1011-6. PubMed ID: 36075597
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microglial mTOR Activation Upregulates Trem2 and Enhances β-Amyloid Plaque Clearance in the
    Shi Q; Chang C; Saliba A; Bhat MA
    J Neurosci; 2022 Jul; 42(27):5294-5313. PubMed ID: 35672148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. mTOR Attenuation with Rapamycin Reverses Neurovascular Uncoupling and Memory Deficits in Mice Modeling Alzheimer's Disease.
    Van Skike CE; Hussong SA; Hernandez SF; Banh AQ; DeRosa N; Galvan V
    J Neurosci; 2021 May; 41(19):4305-4320. PubMed ID: 33888602
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mammalian target of rapamycin: a valid therapeutic target through the autophagy pathway for Alzheimer's disease?
    Cai Z; Zhao B; Li K; Zhang L; Li C; Quazi SH; Tan Y
    J Neurosci Res; 2012 Jun; 90(6):1105-18. PubMed ID: 22344941
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Moxibustion at acpoints of governor vessel on regulating PI3K/Akt/mTOR signaling pathway and enhancing autophagy process in APP/PS1 double-transgenic Alzheimer's disease mice].
    Zhang LD; Han W; Zhu CF; Song XG; Cheng H; Yang K; Qin XF; Zhang JY; Gui L
    Zhongguo Zhen Jiu; 2019 Dec; 39(12):1313-8. PubMed ID: 31820607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular interplay between mammalian target of rapamycin (mTOR), amyloid-beta, and Tau: effects on cognitive impairments.
    Caccamo A; Majumder S; Richardson A; Strong R; Oddo S
    J Biol Chem; 2010 Apr; 285(17):13107-20. PubMed ID: 20178983
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of mTOR protects the blood-brain barrier in models of Alzheimer's disease and vascular cognitive impairment.
    Van Skike CE; Jahrling JB; Olson AB; Sayre NL; Hussong SA; Ungvari Z; Lechleiter JD; Galvan V
    Am J Physiol Heart Circ Physiol; 2018 Apr; 314(4):H693-H703. PubMed ID: 29351469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined induction of mTOR-dependent and mTOR-independent pathways of autophagy activation as an experimental therapy for Alzheimer's disease-like pathology in a mouse model.
    Pupyshev AB; Belichenko VM; Tenditnik MV; Bashirzade AA; Dubrovina NI; Ovsyukova MV; Akopyan AA; Fedoseeva LA; Korolenko TA; Amstislavskaya TG; Tikhonova MA
    Pharmacol Biochem Behav; 2022 Jun; 217():173406. PubMed ID: 35609863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alteration of the Wnt/GSK3β/β‑catenin signalling pathway by rapamycin ameliorates pathology in an Alzheimer's disease model.
    Chen J; Long Z; Li Y; Luo M; Luo S; He G
    Int J Mol Med; 2019 Jul; 44(1):313-323. PubMed ID: 31115485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic reduction of mammalian target of rapamycin ameliorates Alzheimer's disease-like cognitive and pathological deficits by restoring hippocampal gene expression signature.
    Caccamo A; De Pinto V; Messina A; Branca C; Oddo S
    J Neurosci; 2014 Jun; 34(23):7988-98. PubMed ID: 24899720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How longevity research can lead to therapies for Alzheimer's disease: The rapamycin story.
    Richardson A; Galvan V; Lin AL; Oddo S
    Exp Gerontol; 2015 Aug; 68():51-8. PubMed ID: 25481271
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alteration of mTOR signaling occurs early in the progression of Alzheimer disease (AD): analysis of brain from subjects with pre-clinical AD, amnestic mild cognitive impairment and late-stage AD.
    Tramutola A; Triplett JC; Di Domenico F; Niedowicz DM; Murphy MP; Coccia R; Perluigi M; Butterfield DA
    J Neurochem; 2015 Jun; 133(5):739-49. PubMed ID: 25645581
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transferrin decorated-nanostructured lipid carriers (NLCs) are a promising delivery system for rapamycin in Alzheimer's disease: An in vivo study.
    Khonsari F; Heydari M; Sharifzadeh M; Valizadeh H; Dinarvand R; Atyabi F
    Biomater Adv; 2022 Jun; 137():212827. PubMed ID: 35929260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapamycin Ameliorates Cognitive Impairments and Alzheimer's Disease-Like Pathology with Restoring Mitochondrial Abnormality in the Hippocampus of Streptozotocin-Induced Diabetic Mice.
    Ding Y; Liu H; Cen M; Tao Y; Lai C; Tang Z
    Neurochem Res; 2021 Feb; 46(2):265-275. PubMed ID: 33140268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early intrathecal infusion of everolimus restores cognitive function and mood in a murine model of Alzheimer's disease.
    Cassano T; Magini A; Giovagnoli S; Polchi A; Calcagnini S; Pace L; Lavecchia MA; Scuderi C; Bronzuoli MR; Ruggeri L; Gentileschi MP; Romano A; Gaetani S; De Marco F; Emiliani C; Dolcetta D
    Exp Neurol; 2019 Jan; 311():88-105. PubMed ID: 30243986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of mammalian target of rapamycin on cognitive dysfunction of Alzheimer's Disease via regulating Homer3].
    Huang YQ; Liu XG; Zhang L; Yu Y; Xue J; Sun JL
    Zhonghua Yi Xue Za Zhi; 2020 May; 100(17):1336-1340. PubMed ID: 32375443
    [No Abstract]   [Full Text] [Related]  

  • 19. Geniposide-mediated protection against amyloid deposition and behavioral impairment correlates with downregulation of mTOR signaling and enhanced autophagy in a mouse model of Alzheimer's disease.
    Zhang Z; Wang X; Zhang D; Liu Y; Li L
    Aging (Albany NY); 2019 Jan; 11(2):536-548. PubMed ID: 30684442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapamycin and mTOR inhibitors probably have therapeutic effects for post-operative cognitive dysfunction.
    Yang C; Zhu B; Shen J; Hu T; Li Z; Hong T
    Med Hypotheses; 2013 Sep; 81(3):487-8. PubMed ID: 23850396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 50.